![Michael Kishbauch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Michael D.
Kishbauch was the founder of OraPharma, Inc., founded in 1996, where the titles held included President & Chief Executive Officer from 1996 to 2004.
Former jobs include Director at ARIAD Pharmaceuticals, Inc. from 2004 to 2008; Independent Director at Progenics Pharmaceuticals, Inc. from 2013 to 2019; Director at Achillion Pharmaceuticals, Inc. from 2013 to 2020; Independent Director at TetraLogic Pharmaceuticals Corp.
from 2014 to 2016; Independent Director at Astria Therapeutics, Inc. from 2016 to 2026; Vice President-Product Planning & Promotion at Ciba-Geigy Corp.
from 1982 to 1992; and President & Chief Operating Officer at MedImmune LLC from 1992 to 1995.
Education includes undergraduate studies at Wesleyan University and an MBA from The Wharton School of the University of Pennsylvania.
Eerdere bekende functies van Michael Kishbauch
| Bedrijven | Functie | Einde |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Directeur/Bestuurslid | 23-01-2026 |
| ACHILLION PHARMACEUTICALS, INC. | Algemeen Directeur | 01-09-2013 |
| PROGENICS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 17-10-2019 |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Directeur/Bestuurslid | 01-12-2016 |
| ARIAD PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-12-2008 |
Opleiding van Michael Kishbauch
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
57
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Ciba-Geigy Corp.
 Ciba-Geigy Corp. Medical SpecialtiesHealth Technology Manufactures physician and surgical equipment | Health Technology |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces drugs for oral diseases | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
TetraLogic Pharmaceuticals Corp.
 TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies MarketScreener 
